2017 Archive

Learn how a deadly pediatric cancer mutates a protein to cause a series of cellular malfunctions.

Read how work by Dr. Thirumala-Devi Kanneganti, PhD, in immune response is being recognized by top professional organizations.

The flu hijacks upper lung cells and turns them into flu factories. Read how an experimental cancer drug targets the flu’s fuel and shuts the factory down.

Being present after the death of a friend or loved one often matters more to those suffering grief than the right words or actions.

Read how experts came together to create surveillance recommendations for children and young adults with hereditary conditions that predispose them to cancer.

Discover how St. Jude is helping cancer survivors manage the long-term effects of treatment and set up screening guidelines for those still in treatment.

St. Jude honors its patients, survivors and their families during the month of September and every day. Watch the video.

The CSTN provides the world’s largest collection of pediatric cancerous tumors for research into novel treatments. Find out more about available resources.

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Find out what makes St. Jude Children’s Research Hospital the best pediatric cancer hospital in the nation.